CRISPR Therapeutics Reports Financial Results for the Three Months Ended March 31, 2017 and Provides Business … – GlobeNewswire (press release)
|
CRISPR Therapeutics Reports Financial Results for the Three Months Ended March 31, 2017 and Provides Business …
GlobeNewswire (press release) BASEL, Switzerland and CAMBRIDGE, Mass., May 11, 2017 (GLOBE NEWSWIRE) — CRISPR Therapeutics, (NASDAQ:CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today reported … Casebia Therapeutics Expands Leadership Team |
